[Federal Register: July 10, 2002 (Volume 67, Number 132)]
[Notices]               
[Page 45764-45765]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10jy02-135]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 2, 2001, and published in the Federal 
Register on October 11, 2001, (66 FR 51970), Noramco Inc., 1400 Olympic 
Drive, Athens, Georgia 30601, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to support its other manufacturing facility with 
manufacturing and analytical testing.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Noramco, Inc. to manufacture the 
listed controlled substances is consistent with the public interest at 
this time. DEA has investigated Noramco, Inc. on a regular basis to 
ensure that the company's registration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic classes 
of controlled substances listed above is granted.


[[Page 45765]]


    Dated: June 24, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-17213 Filed 7-9-02; 8:45 am]
BILLING CODE 4410-09-M